NEW YORK, March 16, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of HeartWare International, Inc. (“HeartWare”) (NASDAQ:HTWR) between June 10, 2014 and January 11, 2016.
You are hereby notified that a securities class action has been commenced in the USDC for the Southern District of New York. If you purchased or otherwise acquired HeartWare securities between June 10, 2014 and January 11, 2016, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/heartware.
The complaint alleges that during the Class Period, HeartWare and certain of its senior executives made false and misleading statements and omitted material information. In particular, it is alleged that after the U.S. Food and Drug Administration issued a Warning Letter identifying numerous manufacturing and other regulatory failures at the Company’s sole manufacturing facility, Defendants falsely assured investors that the Company had addressed those problems, and that these concerns therefore posed no risk to the clinical trials or timely approval of MVAD, a pump that HeartWare is developing.
Following a series of disclosures regarding adverse effects in certain clinical trial patients, shares of HeartWare have declined from a close of $87.73 per share on June 25, 2014, to a close of just $34.50 per share on January 22, 2016.
If you suffered a loss in HeartWare you have until March 22, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/heartware.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
John Ternus Signals Apple’s Future with Product-First AI Strategy
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 



